Endothelial Cell Responses to Biomechanical Forces in Lymphatic Vessels

Antioxidants and Redox Signaling

Volumn 25, Issue 7, 2016, Pages 451-465

  Sabine, Amélie ^a   Saygili Demir, Cansaran ^a   Petrova, Tatiana V ^a,b,c  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c SWISS INST FOR EXP CANCER RESEARCH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS; BIOCHEMICAL ANALYSIS; BIOMECHANICS; BLOOD VESSEL FUNCTION; CHRONIC INFLAMMATION; DIABETES MELLITUS; ENDOTHELIUM CELL; FORCE; GENE; GENE MUTATION; HUMAN; LYMPH FLOW; LYMPH VESSEL; LYMPH VESSEL ENDOTHELIUM; LYMPHANGIOGENESIS; LYMPHATIC SYSTEM DISEASE; LYMPHEDEMA; MOLECULAR DYNAMICS; MORPHOGENESIS; NEOPLASM; NONHUMAN; OBESITY; PRIORITY JOURNAL; REVIEW; SHEAR STRESS; SIGNAL TRANSDUCTION; TRANSPORT KINETICS; VASCULAR DISEASE; VASCULARIZATION; ANIMAL; CYTOLOGY; DISEASE PREDISPOSITION; MAMMAL; MECHANICAL STRESS; MECHANOTRANSDUCTION; PHYSIOLOGY; SHEAR STRENGTH;

ANIMALS; DISEASE SUSCEPTIBILITY; ENDOTHELIAL CELLS; HUMANS; LYMPHANGIOGENESIS; LYMPHATIC VESSELS; MAMMALS; MECHANOTRANSDUCTION, CELLULAR; SHEAR STRENGTH; STRESS, MECHANICAL;

EID: 84984788968     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2016.6685     Document Type: Review

References (120)

1. AldersM, Al-Gazali L, Cordeiro I, Dallapiccola B, Garavelli L, Tuysuz B, Salehi F, Haagmans MA,Mook OR,MajoieCB, MannensMM, and Hennekam RC. Hennekam syndrome can be caused by FAT4 mutations and be allelic to Van Maldergem syndrome. Hum Genet 133: 1161-1167, 2014.
2. Alders M, Hogan BM, Gjini E, Salehi F, Al-Gazali L, Hennekam EA, Holmberg EE, Mannens MMAM, Mulder MF, Offerhaus GJA, Prescott TE, Schroor EJ, Verheij JBGM, Witte M, Zwijnenburg PJ, Vikkula M, Schulte-Merker S, and Hennekam RC. Mutations in CCBE1 cause generalized lymph vessel dysplasia in humans. Nat Genet 41: 1272-1274, 2009.
3. Avraham T, Daluvoy S, Zampell J, Yan A, Haviv YS, Rockson SG, and Mehrara BJ. Blockade of Transforming Growth Factor-b1 Accelerates Lymphatic Regeneration during Wound Repair. Am J Pathol 177: 3202-3214, 2010.
4. Avraham T, Yan A, Zampell JC, Daluvoy SV, Haimovitz-Friedman A, Cordeiro AP, and Mehrara BJ. Radiation therapy causes loss of dermal lymphatic vessels and interferes with lymphatic function by TGF-beta1-mediated tissue fibrosis. Am J Physiol Cell Physiol 299: C589-605, 2010.
5. Baeyens N, Nicoli S, Coon BG, Ross TD, Van den Dries K, Han J, Lauridsen HM, Mejean CO, Eichmann A, Thomas JL, Humphrey JD, Schwartz MA, and Watt FM. Vascular remodeling is governed by a VEGFR3-dependent fluid shear stress set point. eLife Sci 4: e04645, 2015.
6. Bagriantsev SN, Gracheva EO, and Gallagher PG. Piezo proteins: regulators of mechanosensation and other cellular processes. J Biol Chem 289: 31673-31681, 2014.
7. Baluk P, Fuxe J, Hashizume H, Romano T, Lashnits E, Butz S, Vestweber D, Corada M, Molendini C, Dejana E, and McDonald DM. Functionally specialized junctions between endothelial cells of lymphatic vessels. J Exp Med 204: 2349-2362, 2007.
8. Bazigou E, Xie S, Chen C,Weston A,Miura N, Sorokin LM, Adams R, Muro AF, Sheppard D, and Mäkinen T. Integrinalpha9 is required for fibronectin matrix assembly during lymphatic valvemorphogenesis. Dev Cell 17: 175-186, 2009.
9. Beckman JA, Paneni F, Cosentino F, and Creager MA. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part II. Eur Heart J 34: 2444-2452, 2013.
10. Bernier-Latmani J, Cisarovsky C, Saygili Demir C, Bruand M, JaquetM, Davanture S, Ragusa S, Siegert S, Dormond O, Benedito R, Radtke F, Luther SA, and Petrova TV. DLL4 promotes continuous adult intestinal lacteal regeneration and dietary fat transport. J Clin Invest 125: 4572-4586, 2015.
11. Bernier-Latmani J, Sabine A, and Petrova TV. Meet me in the middle: dual origins of dermal lymphatic vasculature in mammals. Circ Res 116: 1630-1632, 2015.
12. Bertram CD, Macaskill C, and Moore JE. Simulation of a chain of collapsible contracting lymphangions with progressive valve closure. J Biomech Eng 133: 011008, 2011.
13. Bohlen HG, Gasheva OY, and Zawieja DC. Nitric oxide formation by lymphatic bulb and valves is a major regulatory component of lymphatic pumping. Am J Physiol Heart Circ Physiol 301: H1897-H1906, 2011.
14. Bohlen HG, Wang W, Gashev A, Gasheva O, and Zawieja D. Phasic contractions of rat mesenteric lymphatics increase basal and phasic nitric oxide generation in vivo. Am J Physiol Heart Circ Physiol 297: H1319-28, 2009.
15. Bos FL, Caunt M, Peterson-Maduro J, Planas-Paz L, Kowalski J, Karpanen T, van Impel A, Tong R, Ernst JA, Korving J, van Es JH, Lammert E, Duckers HJ, and Schulte-Merker S. CCBE1 is essential for mammalian lymphatic vascular development and enhances the lymphangiogenic effect of vascular endothelial growth factor-C in vivo. Circ Res 109: 486-491, 2011.
16. Bouvreé K, Brunet I, del Toro R, Gordon E, Prahst C, Cristofaro B, Mathivet T, Xu Y, Soueid J, Fortuna V, Miura N, Aigrot M-S, Maden CH, Ruhrberg C, Thomas JL, and Eichmann A. Semaphorin3A, Neuropilin-1, and PlexinA1 are required for lymphatic valve formation. Circ Res 111: 437-445, 2012.
17. Breslin JW, Gaudreault N, Watson KD, Reynoso R, Yuan SY, and Wu MH. Vascular endothelial growth factor-C stimulates the lymphatic pump by a VEGF receptor-3-dependent mechanism. Am J Physiol Heart Circ Physiol 293: H709-H718, 2007.
18. Brice G, Mansour S, Bell R, Collin J, Child A, Brady A, Sarfarazi M, Burnand K, Jeffery S, Mortimer P, and Murday V. Analysis of the phenotypic abnormalities in lymphoedema-distichiasis syndrome in 74 patients with FOXC2 mutations or linkage to 16q24. J Med Genet 39: 478-483, 2002.
19. Bridenbaugh EA, Nizamutdinova IT, Jupiter D, Nagai T, Thangaswamy S, Chatterjee V, and Gashev AA. Lym-phatic muscle cells in rat mesenteric lymphatic vessels of various ages. Lymphat Res Biol 11: 35-42, 2013.
20. Buschmann I, Pries A, Styp-Rekowska B, Hillmeister P, Loufrani L, Henrion D, Shi Y, Duelsner A, Hoefer I, Gatzke N, Wang H, Lehmann K, Ulm L, Ritter Z, Hauff P, Hlushchuk R, Djonov V, van Veen T, and Le Noble F. Pulsatile shear and Gja5 modulate arterial identity and remodeling events during flow-driven arteriogenesis. Development 137: 2187-2196, 2010.
21. Cannon WB. Organization for physiological homeostasis. Physiol Rev 9: 399-431, 1929.
22. Card CM, Yu SS, and Swartz MA. Emerging roles of lymphatic endothelium in regulating adaptive immunity. J Clin Invest 124: 943-952, 2014.
23. Chen C-Y, Bertozzi C, Zou Z, Yuan L, Lee JS, Lu M, Stachelek SJ, Srinivasan RS, Guo L, Vicente A, Vincente A, Mericko P, Levy RJ, Mäkinen T, Oliver G, and Kahn ML. Blood flow reprograms lymphatic vessels to blood vessels. J Clin Invest 122: 2006-2017, 2012.
24. Cheng C, van Haperen R, de Waard M, van Damme LCA, Tempel D, Hanemaaijer L, van Cappellen GWA, Bos J, Slager CJ, Duncker DJ, van der Steen AFW, de Crom R, and Krams R. Shear stress affects the intracellular distribution of eNOS: direct demonstration by a novel in vivo technique. Blood 106: 3691-3698, 2005.
25. Cheung ZH and Ip NY. Cdk5: a multifaceted kinase in neurodegenerative diseases. Trends Cell Biol 22: 169-175, 2012.
26. Chiu J-J and Chien S. Effects of disturbed flow on vascular endothelium: pathophysiological basis and clinical perspectives. Physiol Rev 91: 327-387, 2011.
27. Choe K, Jang JY, Park I, Kim Y, Ahn S, Park D-Y, Hong Y-K, Alitalo K, Koh GY, and Kim P. Intravital imaging of intestinal lacteals unveils lipid drainage through contractility. J Clin Invest 125: 4042-4052, 2015.
28. Clavin NW, Avraham T, Fernandez J, Daluvoy SV, Soares MA, Chaudhry A, and Mehrara BJ. TGF-b1 is a negative regulator of lymphatic regeneration during wound repair. Am J Physiol Heart Circ Physiol 295: H2113-H2127, 2008.
29. Coso S, Bovay E, and Petrova TV. Pressing the right buttons: signaling in lymphangiogenesis. Blood 123: 2614-2624, 2014.
30. Danussi C, Del Bel Belluz L, Pivetta E, Modica TME, Muro A, Wassermann B, Doliana R, Sabatelli P, Colombatti A, and Spessotto P. EMILIN1/a9b1 integrin interaction is crucial in lymphatic valve formation and maintenance. Mol Cell Biol 33: 4381-4394, 2013.
31. Dellinger M, Hunter R, Bernas M, Gale N, Yancopoulos G, Erickson R, and Witte M. Defective remodeling and maturation of the lymphatic vasculature in Angiopoietin-2 deficient mice. Dev Biol 319: 309-320, 2008.
32. Dixon JB, Greiner ST, Gashev AA, Cote GL, Moore JE, and Zawieja DC. Lymph flow, shear stress, and lymphocyte velocity in rat mesenteric prenodal lymphatics. Microcirculation 13: 597-610, 2006.
33. Duong T, Koopman P, and Francois M. Tumor lymphangiogenesis as a potential therapeutic target. J Oncol 2012: 1-23, 2012.
34. Dupont S, Morsut L, Aragona M, Enzo E, Giulitti S, Cordenonsi M, Zanconato F, Le Digabel J, Forcato M, Bicciato S, Elvassore N, and Piccolo S. Role of YAP/TAZ in mechanotransduction. Nature 474: 179-183, 2011.
35. Erickson R, Dagenais S, Caulder M, Downs C, Herman G, Jones M, Kerstjens-Frederi W, Lidral A, McDonald M, Nelson C, Witte M, and Glover T. Clinical heterogeneity in lymphoedema-distichiasis with FOXC2 truncating mutations. J Med Genet 38: 761-766, 2001.
36. Fang J, Dagenais SL, Erickson RP, Arlt MF, Glynn MW, Gorski JL, Seaver LH, and Glover TW. Mutations in FOXC2 (MFH-1), a forkhead family transcription factor, are responsible for the hereditary lymphedema-distichiasis syndrome. Am J Hum Genet 67: 1382-1388, 2000.
37. Fotiou E, Martin-Almedina S, Simpson MA, Lin S, Gordon K, Brice G, Atton G, Jeffery I, Rees DC, Mignot C, Vogt J, Homfray T, Snyder MP, Rockson SG, Jeffery S, Mortimer PS, Mansour S, and Ostergaard P. Novel mutations in PIEZO1 cause an autosomal recessive generalized lymphatic dysplasia with non-immune hydrops fetalis. Nat Commun 6: 8085, 2015.
38. Gale NW, Thurston G, Hackett SF, Renard R, Wang Q, McClain J, Martin C, Witte C, Witte MH, Jackson D, Suri C, Campochiaro PA, Wiegand SJ, and Yancopoulos GD. Angiopoietin-2 Is Required for Postnatal Angiogenesis and Lymphatic Patterning, and Only the Latter Role Is Rescued by Angiopoietin-1. Dev Cell 3: 411-423, 2002.
39. Gashev AA and Chatterjee V. Aged lymphatic contractility: recent answers and new questions. Lymphat Res Biol 11: 2-13, 2013.
40. Gashev AA, Davis MJ, and Zawieja DC. Inhibition of the active lymph pump by flow in rat mesenteric lymphatics and thoracic duct. J Physiol (Lond) 540: 1023-1037, 2002.
41. Gordon K, Schulte D, Brice G, Simpson MA, Roukens MG, van Impel A, Connell F, Kalidas K, Jeffery S, Mortimer PS, Mansour S, Schulte-Merker S, and Ostergaard P. Mutation in vascular endothelial growth factor-C, a ligand for vascular endothelial growth factor receptor-3, is associated with autosomal dominant milroylike primary lymphedema. Circ Res 112: 956-960, 2013.
42. Greene AK, Grant FD, and Slavin SA. Lower-Extremity Lymphedema and Elevated Body-Mass Index. N Engl J Med 366: 2136-2137, 2012.
43. Haemmerle M, Keller T, Egger G, Schachner H, Steiner CW, Stokic D, Neumayer C, Brown MK, Kerjaschki D, and Hantusch B. Enhanced lymph vessel density, remodeling, and inflammation are reflected by gene expression signatures in dermal lymphatic endothelial cells in type 2 diabetes. Diabetes 62: 2509-2529, 2013.
44. Hahn CN, Chong C-E, Carmichael CL, Wilkins EJ, Brautigan PJ, Li X-C, Babic M, Lin M, Carmagnac A, Lee YK, Kok CH, Gagliardi L, Friend KL, Ekert PG, Butcher CM, Brown AL, Lewis ID, To LB, Timms AE, Storek J, Moore S, Altree M, Escher R, Bardy PG, Suthers GK, D'Andrea RJ, Horwitz MS, and Scott HS. Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia. Nat Genet 43: 1012-1017, 2011.
45. Hakanpaa L, Sipila T, Leppänen V-M, Gautam P, Nurmi H, Jacquemet G, Eklund L, Ivaska J, Alitalo K, and Saharinen P. Endothelial destabilization by angiopoietin-2 via integrin b1 activation. Nat Commun 6: 5962, 2015.
46. Harvey NL, Srinivasan RS, Dillard ME, Johnson NC, Witte MH, Boyd K, Sleeman MW, and Oliver G. Lymphatic vascular defects promoted by Prox1 haploinsufficiency cause adult-onset obesity. Nat Genet 37: 1072-1081, 2005.
47. Hong Y-K, Harvey NL, Noh YH, Schacht V, Hirakawa S, Detmar M, and Oliver G. Prox1 is a master control gene in the program specifying lymphatic endothelial cell fate. Dev Dyn 225: 351-357, 2002.
48. Ivanov KI, Agalarov Y, Valmu L, Samuilova O, Liebl J, Houhou N, Maby-El Hajjami H, Norrmén C, Jaquet M, Miura N, Zangger N, Ylä-Herttuala S, Delorenzi M, and Petrova TV. Phosphorylation regulates FOXC2-mediated transcription in lymphatic endothelial cells. Mol Cell Biol 33: 3749-3761, 2013.
49. Jahnsen ED, Trindade A, Zaun HC, Lehoux S, Duarte A, and Jones EAV. Notch1 is pan-endothelial at the onset of flow and regulated by flow. PLoS ONE 10: e0122622, 2015.
50. Jain RK, Martin JD, and Stylianopoulos T. The role of mechanical forces in tumor growth and therapy. Annu Rev Biomed Eng 16: 321-346, 2014.
51. Jeltsch M, Jha SK, Tvorogov D, Anisimov A, Leppänen V-M, Holopainen T, Kivelä R, Ortega S, Karpanen T, and Alitalo K. CCBE1 enhances lymphangiogenesis via A disintegrin and metalloprotease with thrombospondin motifs-3-mediated vascular endothelial growth factor-C activation. Circulation 129: 1962-1971, 2014.
52. Johnson NC, Dillard ME, Baluk P, McDonald DM, Harvey NL, Frase SL, and Oliver G. Lymphatic endothelial cell identity is reversible and its maintenance requires Prox1 activity. Genes Dev 22: 3282-3291, 2008.
53. Jurisic G, Hajjami HM-E, Karaman S, Ochsenbein AM, Alitalo A, Siddiqui SS, Pereira CO, Petrova TV, and Detmar M. An unexpected role of semaphorin3A/neuropilin-1 signaling in lymphatic vessel maturation and valve formation. Circ Res 111: 426-436, 2012.
54. Kampmeier OF. The genetic history of the valves in the lymphatic system of man. Am J Anat 40: 413-457, 1928.
55. Kanady JD, Dellinger MT, Munger SJ, Witte MH, and Simon AM. Connexin37 and Connexin43 deficiencies in mice disrupt lymphatic valve development and result in lymphatic disorders including lymphedema and chylothorax. Dev Biol 354: 253-266, 2011.
56. Karkkainen MJ, Ferrell RE, Lawrence EC, Kimak MA, Levinson KL, McTigue MA, Alitalo K, and Finegold DN. Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema. Nat Genet 25: 153-159, 2000.
57. Karkkainen MJ, Haiko P, Sainio K, Partanen J, Taipale J, Petrova TV, Jeltsch M, Jackson DG, Talikka M, Rauvala H, Betsholtz C, and Alitalo K. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat Immunol 5: 74-80, 2004.
58. Kawai Y, Yokoyama Y, Kaidoh M, and Ohhashi T. Shear stress-induced ATP-mediated endothelial constitutive nitric oxide synthase expression in human lymphatic endothelial cells. Am J Physiol Cell Physiol 298: C647-C655, 2010.
59. Kazenwadel J, Betterman KL, Chong C-E, Stokes PH, Lee YK, Secker GA, Agalarov Y, Saygili Demir C, Lawrence DM, Sutton DL, Tabruyn SP, Miura N, Salminen M, Petrova TV, Matthews JM, Hahn CN, Scott HS, and Harvey NL. GATA2 is required for lymphatic vessel valve development and maintenance. J Clin Invest 125: 2979-2994, 2015.
60. Kazenwadel J, Secker GA, Liu YJ, Rosenfeld JA, Wildin RS, Cuellar-Rodriguez J, Hsu AP, Dyack S, Fernandez CV, Chong C-E, Babic M, Bardy PG, Shimamura A, Zhang MY, Walsh T, Holland SM, Hickstein DD, Horwitz MS, Hahn CN, Scott HS, and Harvey NL. Loss-offunction germline GATA2 mutations in patients with MDS/AML or MonoMAC syndrome and primary lymphedema reveal a key role for GATA2 in the lymphatic vasculature. Blood 119: 1283-1291, 2012.
61. Klotz L, Norman S, Vieira JM, Masters M, Rohling M, Dubé KN, Bollini S, Matsuzaki F, Carr CA, and Riley PR. Cardiac lymphatics are heterogeneous in origin and respond to injury. Nature 522: 62-67, 2015.
62. Kudo FA, Muto A, Maloney SP, Pimiento JM, Bergaya S, Fitzgerald TN, Westvik TS, Frattini JC, Breuer CK, Cha CH, Nishibe T, Tellides G, Sessa WC, and Dardik A. Venous identity is lost but arterial identity is not gained during vein graft adaptation. Arterioscler Thromb Vasc Biol 27: 1562-1571, 2007.
63. Le Guen L, Karpanen T, Schulte D, Harris NC, Koltowska K, Roukens G, Bower NI, van Impel A, Stacker SA, Achen MG, Schulte-Merker S, and Hogan BM. Ccbe1 regulates Vegfc-mediated induction of Vegfr3 signaling during embryonic lymphangiogenesis. Development 141: 1239-1249, 2014.
64. Le Noble F, Moyon D, Pardanaud L, Yuan L, Djonov V, Matthijsen R, Breant C, Fleury V, and Eichmann A. Flow regulates arterial-venous differentiation in the chick embryo yolk sac. Development 131: 361-375, 2004.
65. Leak LV and Burke JF. Ultrastructural studies on the lymphatic anchoring filaments. J Cell Biol 36: 129-149, 1968.
66. Lee KM, Danuser R, Stein JV, Graham D, Nibbs RJ, and Graham GJ. The chemokine receptors ACKR2 and CCR2 reciprocally regulate lymphatic vessel density. EMBO J 33: 2564-2580, 2014.
67. Leu AJ, Gretener SB, Enderlin S, Brühlmann P, Michel BA, Kowal-Bielecka O, Hoffmann U, and Franzeck UK. Lymphatic microangiopathy of the skin in systemic sclerosis. Rheumatology 38: 221-227, 1999.
68. Levental KR, Yu H, Kass L, Lakins JN, Egeblad M, Erler JT, Fong SFT, Csiszar K, Giaccia A, Weninger W, Yamauchi M, Gasser DL, and Weaver VM. Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling. Cell 139: 891-906, 2009.
69. Levet S, Ciais D, Merdzhanova G, Mallet C, Zimmers TA, Lee S-J, Navarro FP, Texier I, Feige J-J, Bailly S, and Vittet D. Bone morphogenetic protein 9 (BMP9) controls lymphatic vessel maturation and valve formation. Blood 122: 598-607, 2013.
70. Li J, Hou B, Tumova S, Muraki K, Bruns A, Ludlow MJ, Sedo A, Hyman AJ, McKeown L, Young RS, Yuldasheva NY,MajeedY,WilsonLA, RodeB, BaileyMA,KimHR, Fu Z, Carter DAL, Bilton J, Imrie H, Ajuh P, Dear TN, Cubbon RM, Kearney MT, Prasad KR, Evans PC, Ainscough JFX, and Beech DJ. Piezo1 integration of vascular architecture with physiological force. Nature 515: 279-282, 2014.
71. Liebl J, Zhang S, Moser M, Agalarov Y, Saygili Demir C, Hager B, Bibb JA, Adams RH, Kiefer F, Miura N, Petrova TV, Vollmar AM, and Zahler S. Cdk5 controls lymphatic vessel development and function by phosphorylation of Foxc2. Nat Commun 6: 7274, 2015.
72. Lim HY, Rutkowski JM, Helft J, Reddy ST, Swartz MA, Randolph GJ, and Angeli V. Hypercholesterolemic mice exhibit lymphatic vessel dysfunction and degeneration. Am J Pathol 175: 1328-1337, 2009.
73. Liu X, Pasula S, Song H, Tessneer KL, Dong Y, Hahn S, Yago T, Brophy ML, Chang B, Cai X, Wu H, McManus J, Ichise H, Georgescu C, Wren JD, Griffin C, Xia L, Sri-nivasan RS, and Chen H. Temporal and spatial regulation of epsin abundance and VEGFR3 signaling are required for lymphatic valve formation and function. Sci Signal 7: ra97-ra97, 2014.
74. Lutter S, Xie S, Tatin F, and Mäkinen T. Smooth muscleendothelial cell communication activates Reelin signaling and regulates lymphatic vessel formation. J Cell Biol 197: 837-849, 2012.
75. Lynch PM, DeLano FA, Schmid-Schonbein GW. The primary valves in the initial lymphatics during inflammation. Lymphat Res Biol 5: 3-10, 2007.
76. Martinez-Corral I, Ulvmar MH, Stanczuk L, Tatin F, Kizhatil K, John SWM, Alitalo K, Ortega S, and Mäkinen T. Nonvenous origin of dermal lymphatic vasculature. Circ Res 116: 1649-1654, 2015.
77. Masumura T, Yamamoto K, Shimizu N, Obi S, and Ando J. Shear stress increases expression of the arterial endothelial marker ephrinB2 in murine ES cells via the VEGFNotch signaling pathways. Arterioscler Thromb Vasc Biol 29: 2125-2131, 2009.
78. Mäkinen T, Adams RH, Bailey J, Lu Q, Ziemiecki A, Alitalo K, Klein R, and Wilkinson GA. PDZ interaction site in ephrinB2 is required for the remodeling of lymphatic vasculature. Genes Dev 19: 397-410, 2005.
79. Mellor RH, Hubert CE, Stanton AWB, Tate N, Akhras V, Smith A, Burnand KG, Jeffery S,Mäkinen T, Levick JR, and Mortimer PS. Lymphatic dysfunction, not aplasia, underlies milroy disease. Microcirculation 17: 281-296, 2010.
80. Miteva DO, Rutkowski JM, Dixon JB, Kilarski W, Shields JD, and Swartz MA. Transmural flow modulates cell and fluid transport functions of lymphatic endothelium. Circ Res 106: 920-931, 2010.
81. Mortimer PS and Rockson SG. New developments in clinical aspects of lymphatic disease. J Clin Invest 124: 915-921, 2014.
82. Mostoslavsky G. Arm lymphoedema after breast cancer. Lancet Oncol 14: 442-443, 2013.
83. Mouta-Bellum C, Kirov A, Miceli-Libby L, Mancini ML, Petrova TV, Liaw L, Prudovsky I, Thorpe PE, Miura N, Cantley LC, Alitalo K, Fruman DA, and Vary CPH. Organ-specific lymphangiectasia, arrested lymphatic sprouting, and maturation defects resulting from genetargeting of the PI3K regulatory isoforms p85a, p55a, and p50a. Dev Dyn 238: 2670-2679, 2009.
84. Murtomaki A, Uh MK, Kitajewski C, Zhao J, Nagasaki T, Shawber CJ, and Kitajewski J. Notch signaling functions in lymphatic valve formation. Development 141: 2446-2451, 2014.
85. Ng CP, Helm C-LE, and Swartz MA. Interstitial flow differentially stimulates blood and lymphatic endothelial cell morphogenesis in vitro. Microvasc Res 68: 258-264, 2004.
86. Norrmén C, Ivanov KI, Cheng J, Zangger N, Delorenzi M, Jaquet M, Miura N, Puolakkainen P, Horsley V, Hu J, Augustin HG, Ylä-Herttuala S, Alitalo K, and Petrova TV. FOXC2 controls formation and maturation of lymphatic collecting vessels through cooperation with NFATc1. J Cell Biol 185: 439-457, 2009.
87. Nutman TB. Insights into the pathogenesis of disease in human lymphatic filariasis. Lymphat Res Biol 11: 144-148, 2013.
88. Oka M, Iwata C, Suzuki HI, Kiyono K, Morishita Y, Watabe T, Komuro A, Kano MR, and Miyazono K. Inhibition of endogenous TGF-b signaling enhances lymphangiogenesis. Blood 111: 4571-4579, 2008.
89. Ostergaard P, Simpson MA, Connell FC, Steward CG, Brice G, Woollard WJ, Dafou D, Kilo T, Smithson S, Lunt P, Murday VA, Hodgson S, Keenan R, Pilz DT, Martinez-Corral I, Mäkinen T, Mortimer PS, Jeffery S, Trembath RC, and Mansour S. Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome). Nat Genet 43: 929-931, 2011.
90. Paneni F, Beckman JA, Creager MA, and Cosentino F. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I. Eur Heart J 34: 2436-2443, 2013.
91. Paskett ED, Dean JA, Oliveri JM, and Harrop JP. Cancerrelated lymphedema risk factors, diagnosis, treatment, and impact: a review. J Clin Oncol 30: 3726-3733, 2012.
92. Petrova TV, Karpanen T, Norrmén C, Mellor RH, Tamakoshi T, Finegold DN, Ferrell RE, Kerjaschki D, Mostoslavsky G, Ylä-Herttuala S, Miura N, and Alitalo K. Defective valves and abnormal mural cell recruitment underlie lymphatic vascular failure in lymphedema distichiasis. Nat Med 10: 974-981, 2004.
93. Petrova TV, Mäkinen T, Mäkelä TP, Saarela J, Virtanen I, Ferrell RE, Finegold DN, Kerjaschki D, Ylä-Herttuala S, and Alitalo K. Lymphatic endothelial reprogramming of vascular endothelial cells by the Prox-1 homeobox transcription factor. EMBO J 21: 4593-4599, 2002.
94. Planas-Paz L, Strilić B, Goedecke A, Breier G, Fässler R, and Lammert E. Mechanoinduction of lymph vessel expansion. EMBO J 31: 788-804, 2011.
95. Platt AM and Randolph GJ. Dendritic cell migration through the lymphatic vasculature to lymph nodes. Adv Immunol 120: 51-68, 2013.
96. Prahst C, Kasaai B, Moraes F, Jahnsen ED, Larrivee B, Villegas D, Pardanaud L, Pibouin-Fragner L, Zhang F, Zaun HC, Eichmann A, and Jones EAV. The H2.0-like homeobox transcription factor modulates yolk sac vascular remodeling in mouse embryos. Arterioscler Thromb Vasc Biol 34: 1468-1476, 2014.
97. Qu X, Zhou B, Scott Baldwin H. Tie1 is required for lymphatic valve and collecting vessel development. Dev Biol 399: 117-128, 2015.
98. Ranade SS, Qiu Z, Woo SH, Hur SS, Murthy SE, Cahalan SM, Xu J, Mathur J, Bandell M, Coste B, Li YSJ, Chien S, and Patapoutian A. Piezo1, a mechanically activated ion channel, is required for vascular development in mice. Proc Natl Acad Sci USA 111: 10347-10352, 2014.
99. Rossi A, Sozio F, Sestini P, Renzoni EA, Khan K, Denton CP, Abraham DJ, and Weber E. Lymphatic and blood vessels in scleroderma skin, a morphometric analysis. Hum Pathol 41: 366-374, 2010.
100. Sabine A, Agalarov Y, Maby-El Hajjami H, Jaquet M, Hägerling R, Pollmann C, Bebber D, Pfenniger A, Miura N, Dormond O, Calmes J-M, Adams RH, Mäkinen T, Kiefer F, Kwak BR, and Petrova TV. Mechanotransduction, PROX1, and FOXC2 cooperate to control connexin37 and calcineurin during lymphatic-valve formation. Dev Cell 22: 430-445, 2012.
101. Sabine A, Bovay E, Saygili Demir C, Kimura W, Jaquet M, Agalarov Y, Zangger N, Scallan JP, Graber W, Gulpinar E, Kwak BR, Mäkinen T, Martinez-Corral I, Ortega S, Delorenzi M, Kiefer F, Davis MJ, Djonov V, Miura N, and Petrova TV. FOXC2 and fluid shear stress stabilize postnatal lymphatic vasculature. J Clin Invest 125: 3861-3877, 2015.
102. Sabine A and Petrova TV. Interplay of mechanotransduction, FOXC2, connexins, and calcineurin signaling in lymphatic valve formation. Adv Anat Embryol Cell Biol 214: 67-80, 2014.
103. Scallan JP, Hill MA, and Davis MJ. Lymphatic vascular integrity is disrupted in type 2 diabetes due to impaired nitric oxide signalling. Cardiovasc Res 107: 89-97, 2015.
104. Schmid-Schonbein GW. The Second Valve System in Lymphatics. Lymphat Res Biol 1: 25-31, 2003.
105. Schulte-Merker S, Sabine A, and Petrova TV. Lymphatic vascular morphogenesis in development, physiology, and disease. J Cell Biol 193: 607-618, 2011.
106. Shen B, Shang Z, Wang B, Zhang L, Zhou F, Li T, Chu M, Jiang H, Wang Y, Qiao T, Zhang J, Sun W, Kong X, and He Y. Genetic dissection of tie pathway in mouse lymphatic maturation and valve development. Arterioscler Thromb Vasc Biol 34: 1221-1230, 2014.
107. Srinivasan RS, Escobedo N, Yang Y, Interiano A, Dillard ME, Finkelstein D, Mukatira S, Gil HJ, Nurmi H, Alitalo K, and Oliver G. The Prox1-Vegfr3 feedback loop maintains the identity and the number of lymphatic endothelial cell progenitors. Genes Dev 28: 2175-2187, 2014.
108. Srinivasan RS and Oliver G. Prox1 dosage controls the number of lymphatic endothelial cell progenitors and the formation of the lymphovenous valves. Genes Dev 25: 2187-2197, 2011.
109. Stacker SA, Williams SP, Karnezis T, Shayan R, Fox SB, and Achen MG. Lymphangiogenesis and lymphatic vessel remodelling in cancer. Nat Rev Mol Cell Biol 14: 159-172, 2014.
110. Stanczuk L, Martinez-Corral I, Ulvmar MH, Zhang Y, Lavinã B, Fruttiger M, Adams RH, Saur D, Betsholtz C, Ortega S, Alitalo K, Graupera M, and Mäkinen T. cKit lineage hemogenic endothelium-derived cells contribute to mesenteric lymphatic vessels. Cell Rep 10: 1708-1721, 2015.
111. Sweet DT, Jiménez JM, Chang J, Hess PR, Mericko-Ishizuka P, Fu J, Xia L, Davies PF, and Kahn ML. Lymph flow regulates collecting lymphatic vessel maturation in vivo. J Clin Invest 125: 2995-3007, 2015.
112. Tatin F, Taddei A, Weston A, Fuchs E, Devenport D, Tissir F, and Mäkinen T. Planar cell polarity protein celsr1 regulates endothelial adherens junctions and directed cell rearrangements during valve morphogenesis. Dev Cell 26: 31-44, 2013.
113. Werner RS, McCormick B, Petrek J, Cox L, Cirrincione C, Gray JR, and Yahalom J. Arm edema in conservatively managed breast cancer: obesity is a major predictive factor. Radiology 180: 177-184, 1991.
114. Wigle JT, Harvey NL, Detmar M, Lagutina I, Grosveld G, Gunn MD, Jackson DG, and Oliver G. An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype. EMBO J 21: 1505-1513, 2002.
115. Yao L-C, Baluk P, Srinivasan RS, Oliver G, and Mc-Donald DM. Plasticity of button-like junctions in the endothelium of airway lymphatics in development and inflammation. Am J Pathol 180: 2561-2575, 2012.
116. Zarkada G, Heinolainen K, Mäkinen T, Kubota Y, and Alitalo K. VEGFR3 does not sustain retinal angiogenesis without VEGFR2. Proc Natl Acad Sci USA 112: 761-766, 2015.
117. Zawieja DC. Contractile Physiology of Lymphatics. Lymphat Res Biol 7: 87-96, 2010.
118. Zhang G, Brady J, Liang W-C, Wu Y, Henkemeyer M, and Yan M. EphB4 forward signalling regulates lymphatic valve development. Nat Commun 6: 6625, 2015.
119. Zheng W, Nurmi H, Appak S, Sabine A, Bovay E, Korhonen EA, Orsenigo F, Lohela M, D'Amico G, Holopainen T, Leow CC, Dejana E, Petrova TV, Augustin HG, and Alitalo K. Angiopoietin 2 regulates the transformation and integrity of lymphatic endothelial cell junctions. Genes Dev 28: 1592-1603, 2014.
120. Zhou F, Chang Z, Zhang L, Hong Y-K, Bin Shen, Wang B, Zhang F, Lu G, Tvorogov D, Alitalo K, Hemmings BA, Yang Z, and He Y. Akt/Protein kinase b is required for lymphatic network formation, remodeling, and valve development. Am J Pathol 177: 2124-2133, 2010.